The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)

Por Venketasubramanian, Narayanaswamy, Lee, Chun Fan, Wong, K. S. Lawrence, Chen, Christopher L. H.
Publicado no J Evid Based Med (2015)

Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation

Por Chen, Christopher L H, Willis, Brian A, Mooney, Louise, Ong, Guan Koon, Lim, Chay Ngee, Lowe, Stephen L, Tauscher-Wisniewski, Sitra, Cutler, Gordon B, Wiss, Stephen D
Publicado em 2010

Prognostic Factors and Pattern of Long-Term Recovery with MLC601 (NeuroAiD™) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery – Extension Study

Por Venketasubramanian, Narayanaswamy, Lee, Chun Fan, Young, Sherry H., Tay, San San, Umapathi, Thirugnanam, Lao, Annabelle Y., Gan, Herminigildo H., Baroque II, Alejandro C., Navarro, Jose C., Chang, Hui Meng, Advincula, Joel M., Muengtaweepongsa, Sombat, Chan, Bernard P.L., Chua, Carlos L., Wijekoon, Nirmala, de Silva, H. Asita, Hiyadan, John Harold B., Suwanwela, Nijasri C., Wong, K.S. Lawrence, Poungvarin, Niphon, Eow, Gaik Bee, Chen, Christopher L.H.
Publicado no Cerebrovasc Dis (2017)